View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Uncategorised
September 7, 2021

Coronavirus company news summary – Omega Diagnostics seeks CE Mark for antigen self-test – NYUAD team uses hair cortisol test to identify Covid-19-related stress levels

By Chloe Kent

Omega Diagnostics Group has submitted all supporting data and documentation necessary to seek a CE mark for its VISITECT COVID-19 antigen test self-test. The test already holds a CE mark for professional use, but this application would permit its sale for at-home use. The company completed the submission process after the conclusion of the test’s useability study by Ulster University.

Exhalation Technology has developed CoronaCheck Lite, a test for rapid Covid-19 diagnosis using nasal swabs and saliva samples. The cost-effective test leverages an electrochemical biosensor and a sensor strip that is placed within a portable handheld and reusable analyser. It can deliver results in five minutes without any sample handling, the company says. Previously, Exhalation Technology developed another rapid Covid-19 test called CoronaCheck, based on its exhaled breath diagnostics expertise.

The Government of Singapore has announced plans to boost pervasive testing and other measures to swiftly identify and lower Covid-19 infections in workplaces. The announcement comes after new infection cases in the community nearly doubled in one week. Beginning next week, the country’s Fast and Easy Test (FET) Rostered Routine Testing (RRT) regime will be updated to raise testing frequency from once a fortnight to once per week. Testing will also be expanded to more workers in higher-risk settings.

Researchers at NYU Abu Dhabi (NYUAD), in alliance with Global TIES for Children and scientists at the University of California Davis and Hashemite University in Jordan, have utilised a hair cortisol test to identify the effect of Covid-19 on stress levels in families. Findings revealed that personalised assistance is needed to support the requirements of families at risk in order to avoid the adverse physiological and psychological impact of the ongoing pandemic.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network